COLLPLANT BIOTECHNOLOGIES LT (CLGN) Stock Income Statement
NASDAQ:CLGN - Nasdaq - IL0004960188 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.47M | 515.00K | 10.96M | 300.00K | 15.64M | |||
| Cost Of Goods | 1.27M | 1.34M | 1.13M | 100.00K | 1.64M | |||
| Gross Profit | 1.20M | -824.00K | 9.83M | 200.00K | 14.00M | |||
| Operating Expenses | 15.77M | 16.14M | 16.48M | 17.00M | 13.57M | |||
| Research and Development | 10.21M | 10.52M | 10.48M | 10.26M | 7.63M | |||
| Selling, General, and Administrative Expenses | 5.56M | 5.63M | 6.00M | 6.74M | 5.94M | |||
| Operating Income | -14.57M | -16.96M | -6.65M | -16.80M | 440.00K | |||
| Interest Income/Expense | 704.00K | 659.00K | 503.00K | 180.00K | 200.00K | |||
| Other Income/Expense | N/A | -17.00K | -10.00K | -10.00K | -30.00K | |||
| Non Recurring Items | N/A | -286.00K | -866.00K | -300.00K | -370.00K | |||
| Income Before Taxes | -13.87M | -16.61M | -7.02M | -16.93M | 240.00K | |||
| Net Income | -13.87M | -16.61M | -7.02M | -16.93M | 240.00K | |||
| EBITDA | -13.57M | -15.93M | -5.54M | -15.72M | 1.21M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.21 | -1.45 | -0.62 | -1.53 | 0.02 | |||
| Non GAAP EPS | -1.22 | -1.46 | -0.46 | -1.53 | -0.01 | |||
| Statistics | ||||||||
| Gross Profit Margin | 48.71% | -160.00% | 89.73% | 66.67% | 89.51% | |||
| Profit Margin | -560.92% | -3225.05% | -64.05% | -5643.33% | 1.53% | |||
| Operating Profit Margin | -589.40% | -3294.17% | -60.64% | -5600.00% | 2.81% | |||
All data in USD